CYTOVIR-3 Anti-viral Peptide Drug

CYTOVIR®-3 has been on the market for over 25 years.
25 years of trust from doctors and patients!

Strengthens the barrier function of the upper and lower respiratory tract.
Specifically inhibits the multiplication of the SARS-CoV-2 virus, which is the causative agent of the new coronavirus infection COVID-19 (in vitro).
During the course of treatment, it maintains the required level of its own interferon, helping to fight viruses.
Increases antioxidant protection of cells and tissues.